<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04984473</url>
  </required_header>
  <id_info>
    <org_study_id>20-009490</org_study_id>
    <nct_id>NCT04984473</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate Breathing Muscle Training in Cardiac Rehab</brief_title>
  <official_title>Combined Cardiac Rehabilitation and Inspiratory Muscle Training in Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to understand if breathing muscle training combined with cardiac&#xD;
      rehabilitation influences the blood flow and blood pressure response during exercise.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Anticipated">October 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood pressure response</measure>
    <time_frame>baseline and 12 week follow up</time_frame>
    <description>Mean arterial pressure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in blood flow response</measure>
    <time_frame>baseline and 12 week follow up</time_frame>
    <description>respiratory muscle blood flow</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in limb vascular resistance response</measure>
    <time_frame>baseline and 12 week follow up</time_frame>
    <description>Limb vascular resistance</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">42</enrollment>
  <condition>Healthy</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Sham arm</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Perform inspiratory muscle training at 2% maximal inspiratory pressure for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-sham arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Perform inspiratory muscle training at 40% maximal inspiratory pressure for 12 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Inspiratory muscle training</intervention_name>
    <description>Inspiratory muscle training for 12 weeks at 40% maximal inspiratory pressure</description>
    <arm_group_label>Non-sham arm</arm_group_label>
    <arm_group_label>Sham arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria - Heart Failure Group:&#xD;
&#xD;
          -  Adult 18 years and older.&#xD;
&#xD;
          -  English speaking.&#xD;
&#xD;
          -  Has a qualifying heart failure indication for center-based cardiac rehabilitation.&#xD;
&#xD;
        Inclusion Criteria - Healthy Control Group:&#xD;
&#xD;
          -  Adult 18 years and older.&#xD;
&#xD;
          -  English speaking.&#xD;
&#xD;
          -  Absence of pulmonary, cardiovascular, musculoskeletal, neurologic, or orthopedic&#xD;
             diseases. Controls will be matched for age and sex.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  HF patients who are unable to engage in a regularly structured exercise training&#xD;
             program as part of a clinically indicated center-based outpatient cardiac&#xD;
             rehabilitation program.&#xD;
&#xD;
          -  Participants unable/unwilling to provide informed consent.&#xD;
&#xD;
          -  Uremia, history of allergy to iodides. Impaired renal function.&#xD;
&#xD;
          -  Creatinine value greater than 1.3 mg/dL (via clinical record within the past 6&#xD;
             months).&#xD;
&#xD;
          -  Diagnosis of liver disease.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Olson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eric Bruhn, MA</last_name>
    <phone>507-266-2690</phone>
    <email>bruhn.eric@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Joshua Smith</last_name>
    <email>smith.joshua1@mayo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Olson, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 14, 2021</study_first_submitted>
  <study_first_submitted_qc>July 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 30, 2021</study_first_posted>
  <last_update_submitted>July 21, 2021</last_update_submitted>
  <last_update_submitted_qc>July 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Thomas P. Olson, M.S., Ph.D.</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

